Clostridium butyricum CBM588 Strain Clinical Trials

1 actively recruiting trial across 1 location

Also known as: C. butyricum CBM588 Strain, C. butyricum MIYAIRI Strain, C. butyricum Strain MIYAIRI 588, CBM588, Clostridium butyricum MIYAIRI 588 +3 more

Pipeline

Phase 2: 1

Top Sponsors

City of Hope Medical Center1

Indications

Stage II Renal Cell Cancer AJCC v81
Stage IV Renal Cell Cancer AJCC v81
Stage III Renal Cell Cancer AJCC v81
Sarcomatoid Renal Cell Carcinoma1
Clear Cell Renal Cell Carcinoma1

Duarte, California1 trial

Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery

City of Hope Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.